Kamal Ashraf, MD

Case Report
Intragraft Nicardipine Prophylaxis to Prevent No-reflow in Triple-vessel Saphenous Vein Graft Intervention
08/01/2008
No-reflow, or slow-reflow, is a common complication during percutaneous coronary intervention in saphenous vein graft (SVG) angioplasty or stenting. No-reflow after SVG intervention is often associated with serious adverse clinical...
No-reflow, or slow-reflow, is a common complication during percutaneous coronary intervention in saphenous vein graft (SVG) angioplasty or stenting. No-reflow after SVG intervention is often associated with serious adverse clinical...
No-reflow, or slow-reflow, is a...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
“Pharmacologic” Distal Protection Using Prophylactic, Intragraft
Nicardipine to Prevent No-Reflow and Non-Q-Wave Myocardial In
08/01/2008
No-reflow is a common complication during percutaneous coronary intervention in degenerated saphenous vein grafts (SVGs), and is associated with serious adverse clinical outcomes.1–6 The important role of microvascular vasoconstriction as a...
No-reflow is a common complication during percutaneous coronary intervention in degenerated saphenous vein grafts (SVGs), and is associated with serious adverse clinical outcomes.1–6 The important role of microvascular vasoconstriction as a...
No-reflow is a common...
08/01/2008
Journal of Invasive Cardiology

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use